• Bullish Stocks
  • Bearish Stocks
  • Volume Shockers
  • Top Gainers
    • Daily Gainers
    • Weekly Gainers
    • Monthly Gainers
  • Top Losers
    • Daily Losers
    • Weekly Losers
    • Monthly Losers
  • Intraday Calls
  • Screeners
    • Multibagger Stocks
    • NR 7 + IB Stocks
    • Narrow CPR Stocks
0 Items
Daily Stock Tips
  • Home
  • Cryptocurrency Ranking
  • News & Education Corner
  • Giveaway NEW
  • Advertise
  • Contact us
Select Page
Moderna, Inc.

Quotes, news, charts and market data on Moderna, Inc.. Find all information needed below.

 

Last updated: 12 mins ago

 

Back to Screener
MRNA
Moderna, Inc.
NasdaqGS
$148.13
9.27
5.89%
asset

EQUITY

Asset Class

industry

Healthcare

Sector

Asset Country

United States

Country

industry

Biotechnology

Industry

AMZN 
$3,124.97  -0.67%  
GOOG 
$2,091.25  0.47%  
MSFT 
$235.77  -0.49%  
TSLA 
$692.04  -3.67%  
FBD.BA 
$34.30  0.59%  
NFLX 
$553.04  0.43%  
PFE 
$33.62  -0.21%  
BRK-A 
$379,920.00  0.57%  
AAPL 
$125.99  -1.41%  
BABA 
$237.07  -1.91%  
SNE 
$106.60  -1.37%  
PYPL 
$272.00  -0.60%  
KO 
$50.31  0.81%  
V 
$216.84  0.10%  
MRNA 
$148.13  -5.89%  
JPM 
$150.90  0.27%  
WMT 
$130.69  -0.52%  
SQ 
$253.75  5.29%  

Moderna, Inc. stock price: $148.13  ($9.27 $9.27)

Open: $153.50 Low: $146.46  High: $154.44 Close: $157.40

Moderna, Inc. stock exchange: 

NMS

Moderna, Inc. market capitalization: 

$59.22B

Moderna, Inc. dividend rate:

  %

Moderna, Inc. dividend yield: 

%

Moderna, Inc. outstanding shares: 

395.71M

Moderna, Inc. EPS: 

-1.959

Moderna, Inc.

Market Data

Moderna, Inc.
Status: Active
Industry: Biotechnology
Exchange: NMS
Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total of 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca, Merck & Co., Vertex Pharmaceuticals, Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, and Bill & Melinda Gates Foundation; and a research collaboration with Harvard University. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of mRNA-1273, a COVID-19 vaccine; and Catalent for fill-finish manufacturing of its COVID-19 vaccine candidate. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Trade. Smarter. Better.

Daily Stock Tips

Daily Stock Tips provides you with market data across asset classes. Ranging from Indian & other stocks, commodities, cryptocurrencies and more.

None of the content is financial advice.

© 2020 dailystocktips.co.in

Resources

Daily Stock Tips 2.0
News Corner
Stocks & Commodities
Cryptocurrency Ranking
Bullish Stocks (India)
Bearish Stocks (India)
Bullish Stocks (India)
Top Gainers (India)

About Us

Contact
Twitter
Facebook
AMZN 
$3,124.97  -0.67%  
GOOG 
$2,091.25  0.47%  
MSFT 
$235.77  -0.49%  
TSLA 
$692.04  -3.67%  
FBD.BA 
$34.30  0.59%  
NFLX 
$553.04  0.43%  
PFE 
$33.62  -0.21%  
BRK-A 
$379,920.00  0.57%  
AAPL 
$125.99  -1.41%  
BABA 
$237.07  -1.91%  
SNE 
$106.60  -1.37%  
PYPL 
$272.00  -0.60%  
KO 
$50.31  0.81%  
V 
$216.84  0.10%  
MRNA 
$148.13  -5.89%  
JPM 
$150.90  0.27%  
WMT 
$130.69  -0.52%  
SQ 
$253.75  5.29%  

This is a demo store for testing purposes — no orders shall be fulfilled. Dismiss

favicon

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team. We won`t spam - there will be a newsletter maximum twice per week. Mostly monthly. :)

You have Successfully Subscribed!